Results 71 to 80 of about 62,301 (266)

COVID-19 infection associated with autoimmune hemolytic anemia

open access: yesAnnals of Hematology, 2020
A 62-y-old man developed Covid-19 infection. Fourteen days after the first respiratory symptoms, he presented biological signs of hemolysis with cold agglutinins 1/16384.
A. Capes   +4 more
semanticscholar   +1 more source

Immunotherapy-associated autoimmune hemolytic anemia

open access: yesJournal for ImmunoTherapy of Cancer, 2017
Background Immunotherapy has been widely used in the treatment of several solid and hematologic malignancies. Checkpoint inhibitors have been the forefront of cancer immunotherapy in recent years.
Uqba Khan   +4 more
doaj   +1 more source

Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment.

open access: yesBlood Advances, 2019
The terminology applied to autoimmune hemolytic anemia (AIHA) seems inconsistent. We aimed to evaluate the consistency of definitions used for diagnosis and treatment.
Q. Hill, A. Hill, S. Berentsen
semanticscholar   +1 more source

Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection

open access: yesAnnals of Hematology, 2020
Higher levels of D-dimer, LDH, and ferritin, all have been associated with the poor prognosis of COVID-19. In a disease where there are acute inflammation and compromised oxygenation, we investigated the impact of initial hemoglobin (Hgb) levels at ...
Abdulrahman A. Algassim   +10 more
semanticscholar   +1 more source

Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activity

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Prednisone is a widely used glucocorticoid in the treatment of lupus, although its dosing is often determined empirically. Prednisolone, the active metabolite of prednisone, is found in its free form in the serum. The goal of this study was to develop a population pharmacokinetic model in patients with systemic lupus erythematosus (SLE ...
Naïm Bouazza   +26 more
wiley   +1 more source

Tegsedi-Induced Warm Antibody Autoimmune Hemolytic Anemia

open access: yesAnnals of Internal Medicine: Clinical Cases
Autoimmune hemolytic anemia is a hemolytic disorder in which antibodies attack erythrocytes, causing their destruction. Many medications have been linked to autoimmune hemolytic anemia, such as antibiotics, chemotherapy agents, and nonsteroidal anti ...
Mariela Di Vanna   +3 more
doaj   +1 more source

Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification. [PDF]

open access: yes, 2020
Since 2013, the International Union of Immunological Societies (IUIS) expert committee (EC) on Inborn Errors of Immunity (IEI) has published an updated phenotypic classification of IEI, which accompanies and complements their genotypic classification ...
Ailal, Fatima   +18 more
core  

Rituximab Use in Warm and Cold Autoimmune Hemolytic Anemia

open access: yesJournal of Clinical Medicine, 2020
Autoimmune hemolytic anemia is a rare condition characterized by destruction of red blood cells with and without involvement of complement. It is associated with significant morbidity and mortality.
I. Murakhovskaya
semanticscholar   +1 more source

Ethnomedicinal Uses, Phytochemistry, Pharmacological Activities, and Toxicology of the Subfamily Gomphrenoideae (Amaranthaceae): A Comprehensive Review

open access: yesChemistry &Biodiversity, EarlyView.
ABSTRACT The subfamily Gomphrenoideae is composed of about 480 accepted species, many of which have been historically used as medicinal plants, reason why they have been studied in terms of chemical profile, biological activity, and safety. This review consolidates the advances in research on this subfamily over the past 47 years, emphasizing its ...
Dayanna Isabel Araque Gelves   +3 more
wiley   +1 more source

Oncologic Emergencies: Immune-Based Cancer Therapies and Complications [PDF]

open access: yes, 2020
Cancer therapies have undergone several recent advancements. Current cancer treatments include immune-based therapies comprised of checkpoint inhibitors, and adoptive immunotherapy; each treatment has the potential for complications that differ from ...
Brém, Elizabeth   +2 more
core  

Home - About - Disclaimer - Privacy